hu14.18-Interleukin-2 Fusion Protein in Treating Young Patients With Recurrent or Refractory Neuroblastoma
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Paul M Sondel, MD, PhD
University of Wisconsin, Madison
Study Chair - Suzanne Shusterman, MD
Dana-Farber Cancer Institute
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
81 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Alberta Children'S Hospital
Calgary, Alberta, Canada
- University of Alberta Hospital
Edmonton, Alberta, Canada
- Children'S & Women'S Hospital of British Columbia
Vancouver, British Columbia, Canada
- Cancercare Manitoba
Winnipeg, Manitoba, Canada
- Iwk Health Centre
Halifax, Nova Scotia, Canada
- Mcmaster Children'S Hospital at Hamilton Health Sciences
Hamilton, Ontario, Canada
- Children'S Hospital of Western Ontario
London, Ontario, Canada
- Children'S Hospital of Eastern Ontario
Ottawa, Ontario, Canada
- Hospital for Sick Children
Toronto, Ontario, Canada
- Hopital Sainte Justine
Montreal, Quebec, Canada
- Montreal Children'S Hospital at Mcgill University Health Center
Montreal, Quebec, Canada
- Centre Hospitalier Universitaire de Quebec
Québec, Canada
- Lurleen Wallace Comprehensive Cancer at University of Alabama - Birmingham
Birmingham, Alabama, United States
- Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
- Childrens Hospital Los Angeles
Los Angeles, California, United States
- Children'S Hospital Central California
Madera, California, United States
- Children'S Hospital of Orange County
Orange, California, United States
- Sutter Cancer Center
Sacramento, California, United States
- Ucsf Comprehensive Cancer Center
San Francisco, California, United States
- Stanford Comprehensive Cancer Center - Stanford
Stanford, California, United States
- Children'S Hospital Cancer Center
Denver, Colorado, United States
- Children'S National Medical Center
Washington D.C., District of Columbia, United States
- University of Florida Shands Cancer Center
Gainesville, Florida, United States
- Sacred Heart Cancer Center at Sacred Heart Hospital
Pensacola, Florida, United States
- St. Joseph'S Cancer Institute at St. Joseph'S Hospital
Tampa, Florida, United States
- Kaplan Cancer Center at St. Mary'S Medical Center
West Palm Beach, Florida, United States
- Mbccop - Medical College of Georgia Cancer Center
Augusta, Georgia, United States
- Children'S Memorial Hospital - Chicago
Chicago, Illinois, United States
- University of Chicago Cancer Research Center
Chicago, Illinois, United States
- Southern Illinois University School of Medicine
Springfield, Illinois, United States
- Indiana University Melvin and Bren Simon Cancer Center
Indianapolis, Indiana, United States
- Markey Cancer Center at University of Kentucky Chandler Medical Center
Lexington, Kentucky, United States
- Kosair Children'S Hospital
Louisville, Kentucky, United States
- Tulane Cancer Center Office of Clinical Research
Alexandria, Louisiana, United States
- Cancercare of Maine at Eastern Maine Medial Center
Bangor, Maine, United States
- Dana-Farber/harvard Cancer Center at Dana Farber Cancer Institute
Boston, Massachusetts, United States
- Floating Hospital for Children at Tufts - New England Medical Center
Boston, Massachusetts, United States
- Barbara Ann Karmanos Cancer Institute
Detroit, Michigan, United States
- Spectrum Health Hospital - Butterworth Campus
Grand Rapids, Michigan, United States
- Breslin Cancer Center at Ingham Regional Medical Center
Lansing, Michigan, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Aug 2005
- Primary completion
- 29 Feb 2008
- Completion
- 31 May 2012
- Last update posted
- 12 Feb 2015
- Registered enrollment
- 39
- Registry id
- NCT00082758
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.